Advanced prototype for continuous crystal sizing

微晶粒度分布的控制在药物剂型的生产中是必不可少的。特别是，获得窄的尺寸分布对于通过Eupraxia pharmacies开发的新技术精确控制治疗剂的释放曲线 ** 至关重要。获得适当粒度的微晶颗粒所需的现有工作流程 ** 对扩大规模和 ** 制造新型抗炎疗法构成了重大障碍。该提案建立在成功完成的ENGAGE** 资助的基础上，旨在共同设计和鉴定一种新型晶体尺寸测量装置。完成的装置必须能够在连续的工作流程中对研磨的晶体群体进行尺寸分离。该设备将测试一种新型脉冲流筛分概念的可行性 **，并检查放大和设计的潜力，以及为制造环境建造的大规模单元 **。

Control of crystallite particle size distribution is essential in the manufacturing of pharmaceutical dosage**forms. In particular, obtaining a narrow size distribution is essential to enable precise control of release profile**of therapeutic agent through novel technology developed by Eupraxia pharmaceuticals. The present workflow**needed to obtain crystallite particles of the appropriate particle size presents a significant barrier to scale up and**manufacturing of a novel anti-inflammatory therapy. This proposal builds on a successful completed ENGAGE**grant and aims to codesign and qualify a novel crystal sizing apparatus. The completed device must be capable**of size segregation of a milled crystal population in a continuous workflow. This device will test the feasibility**of a novel pulse-flow sieving concept and examine the potential for scale-up and design and a large-scale unit**built for a manufacturing environment.